Live Breaking News & Updates on Pfizer Vaccine India

Stay updated with breaking news from Pfizer vaccine india. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Approval for Pfizer, Moderna Covid-19 vaccines under consideration: Govt


Approval for Pfizer, Moderna Covid-19 vaccines under consideration: Govt
Premium
(HT PRINT)
Read Full Story
The central government is in discussions with American pharmaceutical companies Pfizer and Moderna over their Covid-19 vaccines, said Dr VK Paul, member (health) of Niti Aayog.
Approval to Pfizer and Moderna is under consideration, Paul said.
MORE FROM THIS SECTIONSee All
Premium Premium
Premium Premium
Premium Premium
Premium Premium
He informed that Pfizer has indicated its vaccines will likely be available in July.
This comes a day after government officials stated that if India enters into procurement deals with Pfizer, Moderna and J&J, then the vaccine supply will be further boosted. This will help the country realise its target of inoculating all adults by the end of the year. ....

Pfizer Vaccine India , Pfizer Coronavirus Vaccine , Pfizer Efficacy , Pfizer India News , India Vaccine News , Moderna Covid Vaccines , Moderna Vaccine India , Vaccines In India , India Vaccination News , ஃபைசர் தடுப்பூசி இந்தியா , இந்தியா தடுப்பூசி செய்தி , தடுப்பு மருந்துகள் இல் இந்தியா ,

DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines


DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines
Vaccines which have been approved by select regulatory bodies will not need to conduct bridging trials, the country s apex drug regulator said on Tuesday.
Vials labelled Moderna, Johnson & Johnson, Pfizer-BioNTech COVID-19 vaccine are seen in this illustration. Photo: ReutersS/Dado Ruvic
Health6 hours ago
New Delhi: In a move that is expected to smooth Pfizer and Moderna’s entry into the market, India’s top drug regulator on Tuesday exempted foreign-made COVD-19 vaccines from post-approval bridging trials in the country, if they are approved by certain health bodies.
Indian Express, companies such as Pfizer and Cipla have asked for these exemptions during negotiations to supply vaccines to the country. However, there does not seem to be any update on Pfizer’s demand to grant indemnity – protecting it from any legal action if the vaccine leads to serious side effects, although an ....

United Kingdom , Himachal Pradesh , New Delhi , Central Drugs Standard Control Organisation , Drugs Administration , European Medicines Agency , Central Drugs Laboratory , Devices Agency , National Control Laboratory , Healthcare Products Regulatory Agency , Serum Institute Of India , Indian Express , India Today , Drugs Controller General , Medical Devices Agency , National Expert Group , Vaccine Administration , Emergency Use , Serum Institute , Bharat Biotech , Bridging Trials , Bridging Trials For Covid Vaccines , Covid 19 , Covid 19 Vaccines , Covid 19 Vaccines Bridging Trials , Covid Vaccines ,